Results 151 to 160 of about 23,468 (210)

Dipyridamole

The Lancet, 1992
M J, Metcalfe, G, Lip, F G, Dunn
openaire   +3 more sources

Dipyridamole

Reactions Weekly, 2023
openaire   +2 more sources

Dipyridamole

Thrombosis and Haemostasis, 1975
E. G Coeugniet, B Søeberg
openaire   +1 more source

The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS)

European Journal of Pharmaceutical Sciences, 2017
Y. Tsume, K. Matsui, A. Searls, Susumu Takeuchi, G. Amidon, Duxin Sun, Gordon L. Amidon   +6 more
semanticscholar   +1 more source

Dipyridamole

Reactions Weekly, 2021
openaire   +2 more sources

Prognostic value of dipyridamole stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a mid-term follow-up study

European Radiology, 2016
G. Pontone, D. Andreini, E. Bertella, M. Loguercio, M. Guglielmo, A. Baggiano, G. Aquaro, S. Mushtaq, S. Salerni, P. Gripari, C. Rossi, C. Segurini, E. Conte, V. Beltrama, M. Giovannardi, F. Veglia, A. Guaricci, A. Bartorelli, P. Agostoni, M. Pepi, P. Masci   +20 more
semanticscholar   +1 more source

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.

The Lancet, 2006
P. Halkes, J. van Gijn, L. Kappelle, P. Koudstaal, A. Algra   +4 more
semanticscholar   +1 more source

An overview of dipyridamole

Thrombosis Research, 1990
openaire   +2 more sources

In Vitro Dissolution of Fluconazole and Dipyridamole in Gastrointestinal Simulator (GIS), Predicting in Vivo Dissolution and Drug-Drug Interaction Caused by Acid-Reducing Agents.

Molecular Pharmaceutics, 2015
K. Matsui, Y. Tsume, G. Amidon, G. Amidon   +3 more
semanticscholar   +1 more source

Dipyridamole

Reactions, 1989
  +4 more sources